ZURICH (Reuters) - Roche said on Friday that European regulators had recommended approval of its drug Avastin as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy. Recommendations for marketing approval by the European Medicine Agency’s Committee…
Source: EU agency recommends Roche drug for type of ovarian cancer
Thursday, June 26, 2014
EU agency recommends Roche drug for type of ovarian cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment